Follow
Binyamin A. Knisbacher
Title
Cited by
Cited by
Year
Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors
N Paz-Yaacov, L Bazak, I Buchumenski, HT Porath, M Danan-Gotthold, ...
Cell reports 13 (2), 267-276, 2015
3042015
Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer
T Ouspenskaia, T Law, KR Clauser, S Klaeger, S Sarkizova, F Aguet, B Li, ...
Nature biotechnology 40 (2), 209-217, 2022
1882022
Genome-wide adaptive complexes to underground stresses in blind mole rats Spalax
X Fang, E Nevo, L Han, EY Levanon, J Zhao, A Avivi, D Larkin, X Jiang, ...
Nature communications 5 (1), 3966, 2014
1692014
Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance
HT Porath, BA Knisbacher, E Eisenberg, EY Levanon
Genome biology 18, 1-12, 2017
1432017
DNA editing by APOBECs: a genomic preserver and transformer
BA Knisbacher, D Gerber, EY Levanon
Trends in Genetics 32 (1), 16-28, 2016
852016
Molecular map of chronic lymphocytic leukemia and its impact on outcome
BA Knisbacher, Z Lin, CK Hahn, F Nadeu, M Duran-Ferrer, KE Stevenson, ...
Nature genetics 54 (11), 1664-1674, 2022
772022
Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment
C Gutierrez, AM Al’Khafaji, E Brenner, KE Johnson, SH Gohil, Z Lin, ...
Nature Cancer 2 (7), 758-772, 2021
572021
Whole-genome sequencing reveals principles of brain retrotransposition in neurodevelopmental disorders
J Jacob-Hirsch, E Eyal, BA Knisbacher, J Roth, K Cesarkas, C Dor, ...
Cell research 28 (2), 187-203, 2018
572018
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
EM Parry, I Leshchiner, R Guièze, C Johnson, E Tausch, SA Parikh, ...
Nature medicine 29 (1), 158-169, 2023
392023
Purifying selection of long dsRNA is the first line of defense against false activation of innate immunity
M Barak, HT Porath, G Finkelstein, BA Knisbacher, I Buchumenski, ...
Genome biology 21, 1-10, 2020
352020
DNA editing of LTR retrotransposons reveals the impact of APOBECs on vertebrate genomes
BA Knisbacher, EY Levanon
Molecular biology and evolution 33 (2), 554-567, 2016
352016
Differential inhibition of LINE1 and LINE2 retrotransposition by vertebrate AID/APOBEC proteins
N Lindič, M Budič, T Petan, BA Knisbacher, EY Levanon, N Lovšin
Retrovirology 10, 1-16, 2013
332013
Transcriptome, genetic editing, and microRNA divergence substantiate sympatric speciation of blind mole rat, Spalax
K Li, L Wang, BA Knisbacher, Q Xu, EY Levanon, H Wang, ...
Proceedings of the National Academy of Sciences 113 (27), 7584-7589, 2016
302016
Simultaneous TE analysis of 19 Heliconiine butterflies yields novel insights into rapid TE-based genome diversification and multiple SINE births and deaths
DA Ray, JR Grimshaw, MK Halsey, JM Korstian, AB Osmanski, ...
Genome biology and evolution 11 (8), 2162-2177, 2019
222019
Integrating networks and comparative genomics reveals retroelement proliferation dynamics in hominid genomes
O Levy, BA Knisbacher, EY Levanon, S Havlin
Science advances 3 (10), e1701256, 2017
212017
Control and automation of multilayered integrated microfluidic device fabrication
S Kipper, L Frolov, O Guy, M Pellach, Y Glick, A Malichi, BA Knisbacher, ...
Lab on a Chip 17 (3), 557-566, 2017
172017
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
E Ten Hacken, T Sewastianik, S Yin, GB Hoffmann, M Gruber, K Clement, ...
Blood cancer discovery 4 (2), 150-169, 2023
162023
DNA and RNA editing of retrotransposons accelerate mammalian genome evolution
BA Knisbacher, EY Levanon
Annals of the New York Academy of Sciences 1341 (1), 115-125, 2015
152015
ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome
EM Parry, CK Lemvigh, S Deng, N Dangle, N Ruthen, BA Knisbacher, ...
Cancer cell 41 (10), 1803-1816. e8, 2023
52023
ZNF683 (Hobit) marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for richter syndrome
CK Lemvigh, EM Parry, SL Deng, NJ Dangle, N Ruthen, BA Knisbacher, ...
Blood 140 (Supplement 1), 1807-1808, 2022
52022
The system can't perform the operation now. Try again later.
Articles 1–20